← ALLEGRO MICROSYSTEMS, INC.
| Annual Trend | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | |
|---|---|---|---|---|---|---|---|---|
| Depreciation and amortization | $64.0m | $48.3m | $48.5m | $50.8m | $71.4m | $64.5m | $67.6m | |
| Amortization of deferred financing costs | $0 | $226k | $101k | $99k | $527k | $2.5m | $2.2m | |
| Deferred income taxes | ($4.9m) | ($18.9m) | $7.5m | ($40.1m) | ($18.6m) | ($16.3m) | ($12.0m) | |
| Impairment of assets held for sale | $0 | $7.1m | $0 | $0 | $0 | $0 | $6.6m | |
| Impairment of long-lived assets | — | — | $0 | $0 | $13.2m | $0 | $0 | |
| Other changes in operating assets and liabilities, net | — | — | — | — | ($21.6m) | ($16.3m) | $41.3m | |
| Net (loss) income | $37.1m | $18.1m | $119.6m | $187.5m | $152.9m | ($72.8m) | ($14.7m) | |
| Stock-based compensation | $1.4m | $49.9m | $33.5m | $61.8m | $42.5m | $41.9m | $47.9m | |
| Loss on change in fair value of forward repurchase contract | — | — | — | $0 | $0 | $34.8m | $0 | |
| Change in fair value of contingent consideration | $0 | ($2.5m) | ($2.0m) | ($2.8m) | $0 | $0 | — | |
| Provisions for inventory and expected credit losses | $3.9m | $5.0m | $6.3m | ($1.4m) | $10.3m | $9.2m | $10.0m | |
| Change in fair value of marketable securities | — | — | ($3.7m) | ($7.5m) | $3.6m | $0 | $0 | |
| Other non-cash reconciling items | — | — | — | $285k | $70k | $7.0m | $653k | |
| Trade accounts receivable | $16.4m | ($9.3m) | ($18.3m) | ($12.5m) | ($8.0m) | $33.1m | ($9.2m) | |
| Accounts receivable - other | $346k | ($28k) | ($2.7m) | $2.2m | ($1.0m) | $155k | ($9.8m) | |
| Inventories | $346k | $7.6m | ($4.5m) | ($75.2m) | ($15.8m) | ($30.2m) | ($6.3m) | |
| Payment to related party | — | — | — | — | $0 | $0 | ($15.0m) | |
| Prepaid expenses and other assets | $2.6m | ($29.0m) | ($19.4m) | ($23.3m) | ($40.2m) | ($4.8m) | $49.4m | |
| Trade accounts payable | ($3.1m) | $15.1m | ($4.3m) | $12.0m | ($12.7m) | $4.0m | $6.0m | |
| Due to and from related party | — | — | ($659k) | $18.3m | $5.2m | $5.1m | ($1.7m) | |
| Accrued expenses and other current and long-term liabilities | ($13.5m) | $14.8m | ($3.4m) | $22.9m | ($21.6m) | ($16.3m) | — | |
| Purchases of intangible assets | — | — | — | $0 | $0 | ($1.2m) | $0 | |
| Investment in debt security | — | — | — | — | $0 | $0 | ($3.5m) | |
| Sales in marketable securities | — | — | ($9.2m) | $0 | $16.2m | $0 | $0 | |
| Borrowings of 2023 term loan facility, net of deferred financing costs | $43.0m | $315.7m | $0 | $0 | $245.5m | $0 | $0 | |
| Repayment of 2020 term loan facility | $0 | ($300.0m) | $0 | $0 | ($25.0m) | $0 | $0 | |
| Net proceeds from 2026 Refinanced Term Loan Facility | — | — | — | $0 | $0 | $193.1m | $285.0m | |
| Repayment of term loan | — | — | $0 | $0 | ($25.6m) | ($105.0m) | ($345.0m) | |
| Finance lease payments | — | — | — | $0 | ($142k) | ($1.2m) | ($1.4m) | |
| Receipts on related party notes receivable | $30.0m | $51.4m | $0 | $2.8m | $3.8m | $1.9m | $0 | |
| Payments for intangible assets | — | — | — | — | $0 | $0 | ($5.0m) | |
| Payments for taxes related to net share settlement of equity awards | $0 | ($27.7m) | ($638k) | ($18.1m) | ($25.9m) | ($16.2m) | ($12.6m) | |
| Property, plant and equipment purchases included in trade accounts payable and accrued expenses | ($1.5m) | ($3.2m) | ($2.0m) | ($16.4m) | ($4.2m) | ($4.5m) | ($4.0m) | |
| Right-of-use assets obtained in exchange for lease liabilities | — | $0 | $3.2m | $4.9m | $10.4m | $7.0m | $1.6m | |
| Net cash provided by operating activities | $81.4m | $120.6m | $156.1m | $193.2m | $181.7m | $61.9m | $163.1m | |
| Purchases of property, plant and equipment | ($45.6m) | ($40.7m) | ($69.9m) | ($79.8m) | ($124.8m) | ($40.0m) | ($38.2m) | |
| Assets held for sale transferred from property, plant and equipment, net | $0 | $26.0m | $0 | $0 | $0 | $16.5m | ($9.8m) | |
| Acquisition of business, net of cash acquired and working capital adjustment | $0 | ($11.6m) | ($14.5m) | ($19.9m) | ($408.1m) | $319k | $0 | |
| Net cash used in investing activities | ($41.7m) | ($68.2m) | ($66.3m) | ($99.7m) | ($516.7m) | ($40.8m) | ($41.7m) | |
| Payments of debt issuance costs | $0 | ($33.0m) | $0 | $0 | ($1.4m) | $0 | $0 | |
| Repayments of other debt | — | — | $0 | $0 | ($842k) | $0 | $0 | |
| Proceeds from issuance of common stock under employee purchase plan | — | — | — | $2.8m | $3.6m | $3.5m | $3.3m | |
| Net proceeds from issuance of common stock | — | — | — | $0 | $0 | $665.9m | $0 | |
| Repurchases of common stock | — | — | — | $0 | $0 | ($853.9m) | $0 | |
| Payments for taxes related to repurchase of common stock | — | — | — | — | $0 | $0 | ($1.7m) | |
| Dividends paid to non-controlling interest | $2.4m | $0 | $0 | ($42k) | $0 | ($19k) | ($23k) | |
| Net cash (used in) provided by financing activities | $82.5m | ($72.2m) | ($5.3m) | ($20.0m) | $198.9m | ($112.1m) | ($77.4m) | |
| Effect of exchange rate changes on cash and cash equivalents and restricted cash | ($5.6m) | $3.9m | $1.4m | ($4.6m) | ($421k) | ($89k) | $277k | |
| Net increase (decrease) in cash and cash equivalents and restricted cash | $116.6m | ($16.0m) | $85.9m | $68.9m | ($136.5m) | ($91.1m) | $44.2m | |
| Cash and cash equivalents and restricted cash at beginning of period | $219.9m | $203.9m | $289.8m | $358.7m | $222.2m | $131.1m | $175.4m | |
| Cash and cash equivalents at beginning of period | $214.5m | $197.2m | $282.4m | $351.6m | $212.1m | $121.3m | $168.8m | |
| Restricted cash at beginning of period | $5.4m | $6.7m | $7.4m | $7.1m | $10.0m | $9.8m | $6.6m | |
| Cash paid for interest | $2.4m | $2.7m | $813k | $1.9m | $10.2m | $22.0m | $19.4m | |
| Cash paid for income taxes, net of refunds | $15.9m | $8.9m | $22.2m | $58.2m | $89.9m | $11.6m | ($27.1m) |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.